In the current study, we report that combination treatments that synergize with radiation in activating the immediate early response through the MAPK cascade upregulate the mevalonate pathway in vivo, thereby triggering repopulation of gliomas through prenylation of the Rho GTPase Rac-1. The gene discussed is RAC1; the disease is central nervous system cancer.